510(k) · Cleared
ClearedFoundation Cage
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Corelink, LLC · MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Cleared on Apr 24, 2008 as substantially equivalent to P980048 (Sulzer Spine-Tech, 2001) and 1 other predicate after a 139-day review. Its family tree reaches back 1 generation to 1999. 126 later devices descend from it.
- Decided
- Apr 24, 2008
- Review
- 139 days
- Class
- Class II
- Product code
- MAX
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 1 generation to P960025 (1999). 2 ancestors in all. 126 later devices descend from it, 5 citing it directly.
- Root · 1 generation backP960025 Brantigen I/F Cage (R) Used with VSP (R) Spine Plates and Pedicle…Depuy Spine, Inc. · 1999
- This deviceK073440 Foundation CageCorelink, LLC · 2008
- Descendant · cites it directly · 82 of its ownK162496 Foundation 3D InterbodyCorelink, LLC · 2017
- Descendant · 2 generations on · 48 of its ownK183064 TxTi IBF SystemInnovasis, Inc. · 2019 · Recalled
- Descendant · 3 generations on · 47 of its ownK201614 TxTiHA IBF System, AxTiHA Stand-Alone ALIF SystemInnovasis, Inc. · 2020 · Recalled
- Descendant · cites it directly · 40 of its ownK121254 Camber Spine Technologies TLS 5.0 Inerbody CageCamber Spine Technologies · 2013
- Descendant · 4 generations on · 38 of its ownK211805 IdentiTi Porous Ti Interbody System, Transcend PEEK Interbody…Alphatec Spine, Inc. · 2021
Showing 5 of 126 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 126 · See all- K162496Foundation 3D InterbodyCorelink, LLC · 2017 · cites it directly82descendants
- K183064TxTi IBF SystemInnovasis, Inc. · 2019 · 2 generations on48descendants
- K201614TxTiHA IBF System, AxTiHA Stand-Alone ALIF SystemInnovasis, Inc. · 2020 · 3 generations on47descendants
- K121254Camber Spine Technologies TLS 5.0 Inerbody CageCamber Spine Technologies · 2013 · cites it directly40descendants
- K211805IdentiTi Porous Ti Interbody System, Transcend PEEK Interbody System, IdentiTi NanoTec…Alphatec Spine, Inc. · 2021 · 4 generations on38descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | P960025 | Brantigen I/F Cage (R) Used with VSP (R) Spine Plates and Pedicle Screws | Depuy Spine, Inc. | 1999 | — |
| 0 (this device) | K073440 | Foundation Cage | Corelink, LLC | 2008 | — |
| +1 | K162496 | Foundation 3D Interbody | Corelink, LLC | 2017 | — |
| +2 | K183064 | TxTi IBF System | Innovasis, Inc. | 2019 | 1 |
| +3 | K201614 | TxTiHA IBF System, AxTiHA Stand-Alone ALIF System | Innovasis, Inc. | 2020 | 1 |
| +1 | K121254 | Camber Spine Technologies TLS 5.0 Inerbody Cage | Camber Spine Technologies | 2013 | — |
| +4 | K211805 | IdentiTi Porous Ti Interbody System, Transcend PEEK Interbody System, IdentiTi… | Alphatec Spine, Inc. | 2021 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 2 | 0 |
| 2014 | 2 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
| 2017 | 9 | 0 |
| 2018 | 6 | 0 |
| 2019 | 4 | 0 |
| 2020 | 8 | 0 |
| 2021 | 7 | 0 |
| 2022 | 15 | 0 |
| 2023 | 17 | 0 |
| 2024 | 22 | 0 |
| 2025 | 17 | 0 |
| 2026 | 15 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MAX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MAX device
- #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | P980048 | Bak/Cervical (Bak/C) Interbody Fusion SystemSummary page 1…ODP MAX 3. Predicate or legally marketed devices which are substantially equivalent: BAK/C Vista Interbody Fusion (P980048 S003) BRANTIGEN I/F CAGE (P960025) 4. Description of the device: The interbody fusion with autogenous bone graft so… | 2001 |
| * | P960025 | Brantigen I/F Cage (R) Used with VSP (R) Spine Plates and Pedicle ScrewsSummary page 1…MAX 3. Predicate or legally marketed devices which are substantially equivalent: BAK/C Vista Interbody Fusion (P980048 S003) BRANTIGEN I/F CAGE (P960025) 4. Description of the device: The interbody fusion with autogenous bone graft solves and provides a logical solution for… | 1999 |
What descends from it? (126)
See all 1265 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MAX devicesMAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.
FDA decisions per year · MAX
29in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MAX
85in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MAX
5in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · MAX
811in 2025
MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 7 | 86 | 0 | 12 |
| 2008 | 35 | 88 | 2 | 19 |
| 2009 | 31 | 102 | 9 | 90 |
| 2010 | 29 | 137 | 0 | 154 |
| 2011 | 49 | 98 | 3 | 201 |
| 2012 | 48 | 69 | 11 (1) | 327 |
| 2013 | 58 | 102 | 0 | 380 |
| 2014 | 58 | 115 | 3 | 366 |
| 2015 | 53 | 113 | 1 | 524 |
| 2016 | 64 | 124 | 6 | 647 |
| 2017 | 76 | 116 | 1 | 596 |
| 2018 | 64 | 114 | 4 | 616 |
| 2019 | 60 | 131 | 1 | 699 |
| 2020 | 56 | 106 | 0 | 640 |
| 2021 | 53 | 109 | 0 | 622 |
| 2022 | 41 | 95 | 1 | 618 |
| 2023 | 30 | 87 | 0 | 576 |
| 2024 | 38 | 91 | 1 | 729 |
| 2025 | 29 | 85 | 5 | 811 |
| 2026 | 18 | 95 | 0 | — |
What is it indicated for?
Foundation TM Cervical Interbody Devices are indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one disc level. DDD is defined as discogenic pain with degeneration of the disc confirmed by patient history and radiographic studies. Foundation Cervical implants are used to facilitate intervertebral body fusion in the cervical spine and are placed via an anterior…
Read the full statement (225 words)
Foundation TM Cervical Interbody Devices are indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one disc level. DDD is defined as discogenic pain with degeneration of the disc confirmed by patient history and radiographic studies. Foundation Cervical implants are used to facilitate intervertebral body fusion in the cervical spine and are placed via an anterior approach at the C3 to C7 disc levels using autograft bone. Foundation Cervical implants are to be used with supplemental fixation. Patients should have at least six (6) weeks of non-operative treatment prior to treatment with an intervertebral cage.
The Foundation TM Lumbar Interbody Devices are indicated for intervertebral body fusion procedures in skeletally mature patients with degenerative disc disease (DDD) of the lumbar spine at one or two contiguous levels from L2-S1. DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved level(s). Foundation TM Lumbar implants are to be used with autogenous bone graft and implanted via an open anterior or posterior approach. Foundation TM Lumbar implants are to be used with supplemental fixation. Patients should have at least six (6) months of non-operative treatment prior to treatment with an intervertebral cage.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K073440 · printed Nov 6, 2026
Cite this page
510(k) Report. “K073440: Foundation Cage.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K073440
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026